1.Martin, JA, Hamilton, BE, Sutton, PD, et al. Centers for Disease Control and Prevention National Center for Health Statistics National Vital Statistics System. Natl Vital Stat Rep. 2007; 56, 1–103.
2.Raphael, D. The health of Canada's children. Part I: Canadian children's health in comparative perspective. Paediatr Child Health. 2010; 15, 23–29.
3.Bahtiyar, MO, Copel, JA. Cardiac changes in the intrauterine growth-restricted fetus. Semin Perinatol. 2008; 32, 190–193.
4.Crispi, F, Bijnens, B, Figueras, F, et al. Fetal growth restriction results in remodeled and less efficient hearts in children. Circulation. 2010; 121, 2427–2436.
5.Gagnon, R, Johnston, L, Murotsuki, J. Fetal placental embolization in the late-gestation ovine fetus: alterations in umbilical blood flow and fetal heart rate patterns. Am J Obstet Gynecol. 1996; 175, 630–672.
6.Gagnon, R, Lamb, T, Richardson, BS. Cerebral circulatory responses of near-term ovine fetuses during sustained fetal placental embolization. Am J Physiol Heart Circ Physiol. 1997; 42, H2001–H2008.
7.Kingdom, J, Huppertz, B, Seaward, G, Kaufmann, P. Development of the placenta villous tree and its consequences for fetal growth. Eur J Obstet Gynecol. 2000; 92, 35–43.
8.Louey, S, Jonker, SS, Giraud, GD, Thornburg, KL. Placental insufficiency decreases cell cycle activity and terminal maturation in fetal sheep cardiomyocytes. J Physiol. 2007; 15, 639–648.
9.Morrison, JL, Botting, KJ, Dyer, JL, et al. Restriction of placental function alters heart development in the sheep fetus. Am J Physiol Regul Integr Comp Physiol. 2007; 293, R306–R313.
10.Rizzo, G, Capponi, A, Cavicchioni, O, Vendola, M, Arduini, D. Low cardiac output to the placenta: an early hemodynamic adaptive mechanism in intrauterine growth restriction. Ultrasound Obstet Gynecol. 2008; 32, 155–159.
11.Barker, DJP, Osmond, C, Winter, PD, Margetts, B. Weight in infancy and death from ischaemic heart disease. The Lancet. 1998; 2, 577–580.
12.Graham, HK, Trafford, AW. Spatial disruption and enhanced degradation of collagen with the transition from compensated ventricular hypertrophy to symptomatic congestive heart failure. Am J Physiol. 2007; 292, H1364–H1372.
13.Czuriga, D, Paulus, WJ, Czuriga, I, et al. Cellular mechanisms for diastolic dysfunction in the human heart. Curr Pharm Biotechno. 2012; 13, 2532–2538.
14.Chen, L, Zhang, J, Gan, TX, et al. Left ventricular dysfunction and associated cellular injury in rats exposed to chronic intermittent hypoxia. J Appl Physiol. 2008; 104, 218–223.
15.Zhao, W, Zhao, T, Chen, Y, Ahokas, RA, Sun, Y. Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats. Mol Cell Biochem. 2008; 317, 43–50.
16.Lucas, JA, Zhang, Y, Kaizheng, PL, et al. Inhibition of transforming growth factor-β signaling induces left ventricular dilation and dysfunction in the pressure overloaded heart. Am J Physiol Heart Circ Physiol. 2010; 298, H424–H432.
17.Kai, H, Kuwahara, F, Tokuda, K, Imaizumi, T. Diastolic dysfunction in hypertensive hearts: role of perivascular inflammation and reactive myocardial fibrosis. Hypertens Res. 2005; 28, 483–490.
18.Ross, JJ, Tranquillo, RT. ECM gene expression correlates with in vitro tissue growth and development in fibrin gel remodeled by neonatal smooth muscle cells. Matrix Biol. 2003; 22, 477–490.
19.Thompson, JA, Richardson, BS, Gagnon, R, Regnault, TRH. Chronic hypoxia interferes with aortic development in the late gestation ovine fetus. J Physiol. 2011; 589, 3319–3332.
20.Lee, DA, Assoku, E, Doyle, V. A specific quantitative assay for collagen synthesis by cells seeded in collagen-based biomaterials using Sirius red F3B precipitation. J Mater Sci Mater Med. 1998; 9, 47–51.
21.Cowell, S, Knauper, V, Stewart, ML. Induction of matrix metalloproteinase activation cascades based on membrane-type matrix metalloproteinase: associated activation of gelantinase A, gelatinase B and collagenase 3. Biochem J. 1998; 331(Pt. 2), 453–458.
22.Nakerakanti, SS, Bujor, AM, Trojanowska, M. CCN2 is required for the TGF-β Induced Activation of Smad1 – Erk1/2 Signaling Network. PLoS One. 2001; 6, e21911.
23.Ghidini, A. Idiopathic fetal growth restriction: a pathophysiologic approach. Obstet Gynecol Surv. 1996; 51, 376–382.
24.Krebs, C, Macara, LM, Leiser, R, Bowman, AW, et al. Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental villous tree. Am J Obstet Gynecol. 1996; 175, 1534–1542.
25.Macara, L, Kingdom, JC, Kohnen, G, et al. Elaboration of stem villous vessels in growth restricted pregnancies with abnormal umbilical artery Doppler waveforms. Br J Obstet Gynaecol. 1995; 102, 807–812.
26.Adler, CP, Costabel, U. Myocardial DNA and cell number under the influence of cytostatics. I. Post mortem investigations of human hearts. Virchows Arch B Cell Pathol Incl Mol Pathol. 1908; 32, 109–125.
27.Burrell, JH, Boyn, AM, Kumarasamy, V, et al. Growth and maturation of cardiac myocytes in fetal sheep in the second half of gestation. Anat Rec A Discov Mol Cell Evol Biol. 2003; 274, 952–961.
28.Hernandez-Andrade, E, Crispi, F, Benavides-Serralde, JA, et al. Contribution of the myocardial performance index and aortic isthmus blood flow index to predicting mortality in preterm growth-restricted fetuses. UltrasoundObstet Gynecol. 2009; 34, 430–436.
29.Benavides-Serralde, A, Scheier, M, Cruz-Martinez, R, et al. Changes in central and peripheral circulation in intrauterine growth-restricted fetuses at different stages of umbilical artery flow deterioration: new fetal cardiac and brain parameters. Gynecol Obstet Invest. 2011; 71, 274–280.
30.Takumi, M. Doppler echocardiographic studies of diastolic cardiac function in the human fetal heart. Kurume Med J. 2001; 48, 59–64.
31.Arduini, D, Rizzo, G, Romanini, C. Changes of pulsatility index from fetal vessels preceding the onset of late decelerations in growth retarded fetuses. Obstet Gynecol. 1992; 79, 605–610.
32.Zahradka, P, Harding, G, Litchie, B, et al. Activation of MMP-2 in response to vascular injury is mediated by phosphatidylinositol 3-kinase-dependent-expression of MTI-MMP. Am J Physiol Heart Circ Physiol. 2004; 287, H2861–H2870.
33.Pacher, P, Beckman, JS, Liaudet, L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007; 87, 315–424.
34.Shah, AM, McDermott, BJ, Grieve, DJ. Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with doxorubicin chemotherapy. Cancer Res. 2010; 70, 9287–9297.
35.Evans, LC, Liu, H, Pinkas, GA, Thompson, LP. Chronic hypoxia increases peroxynitrite, MMP-9 expression and collagen accumulation in fetal guinea pig hearts. Pediatr Res. 2011; 71, 25–31.